Indicators

Markets:

News

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

August 06, 2024

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs

July 26, 2024

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

July 23, 2024

5 things to know before the stock market opens Monday

July 22, 2024

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

June 28, 2024

Cramer's Lightning Round: 'I would not abandon' Cava

June 24, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

Cramer's Lightning Round: Apple is a buy

May 28, 2024

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

May 23, 2024

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations

April 29, 2024

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

April 25, 2024

5 things to know before the stock market opens Monday

April 22, 2024

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

April 09, 2024

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

March 01, 2024

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

February 13, 2024

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

February 08, 2024

Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch

February 02, 2024

Bristol Myers Squibb results top estimates as new drugs post strong sales growth

February 02, 2024

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

January 30, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

January 28, 2024

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

January 26, 2024

Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'

January 08, 2024

Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care

January 08, 2024

Cramer names biopharma companies to watch as industry mergers start to pile up

January 05, 2024

Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference

January 05, 2024

Biden administration's Medicare drug price negotiations will face major tests in 2024

December 28, 2023

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

December 22, 2023

Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios

December 18, 2023

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.